FDAnews Drug Daily Bulletin

INTERMUNE THIRD-QUARTER NET LOSS WIDENS

Nov. 1, 2005
A A

Biotechnology company InterMune Inc. (ITMN.O: Quote, Profile, Research) on Thursday said its third-quarter net loss widened due to an inventory charge and higher expenses. The Brisbane, California-based company reported a net loss of $23.8 million, or 74 cents per share, compared with a loss of $12.9 million, or 40 cents a share, a year earlier.

Reuters (http://today.reuters.com/investing/financeArticle.aspx?type=marketsNews&storyID=2005-10-27T200527Z_01_WEN2653_RTRIDST_0_HEALTH-INTERMUNE-EARNS-URGENT.XML)